Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1753

1.

C-C Motif Chemokine Ligand 15 May Be a Useful Biomarker for Predicting the Prognosis of Patients with Chronic Hypersensitivity Pneumonitis.

Watanabe M, Horimasu Y, Iwamoto H, Yamaguchi K, Sakamoto S, Masuda T, Nakashima T, Miyamoto S, Ohshimo S, Fujitaka K, Hamada H, Kohno N, Hattori N.

Respiration. 2019 Aug 15:1-9. doi: 10.1159/000500576. [Epub ahead of print]

PMID:
31416084
2.

Platinum-doublet chemotherapy followed by pembrolizumab therapy for lung cancer with lymphangitis carcinomatosa mimicking interstitial pneumonitis: A case report.

Yamasaki M, Funaishi K, Kawamoto K, Matsumoto Y, Matsumoto N, Taniwaki M, Ohashi N, Hattori N.

Medicine (Baltimore). 2019 Aug;98(33):e16834. doi: 10.1097/MD.0000000000016834.

3.

[EVALUATION OF A MOTOR AND SENSORY DISTURBANCE QUESTIONNAIRE FOR PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS].

Ueki Y, Oshikata C, Asai Y, Kaneko T, Hattori N, Tsurikisawa N.

Arerugi. 2019;68(7):857-868. doi: 10.15036/arerugi.68.857. Japanese.

PMID:
31406082
4.

Convolutional neural network-based segmentation can help in assessing the substantia nigra in neuromelanin MRI.

Le Berre A, Kamagata K, Otsuka Y, Andica C, Hatano T, Saccenti L, Ogawa T, Takeshige-Amano H, Wada A, Suzuki M, Hagiwara A, Irie R, Hori M, Oyama G, Shimo Y, Umemura A, Hattori N, Aoki S.

Neuroradiology. 2019 Aug 10. doi: 10.1007/s00234-019-02279-w. [Epub ahead of print]

PMID:
31401723
5.

Pilot feasibility study of a semi-automated three-dimensional scoring system for cervical dystonia.

Nakamura T, Sekimoto S, Oyama G, Shimo Y, Hattori N, Kajimoto H.

PLoS One. 2019 Aug 8;14(8):e0219758. doi: 10.1371/journal.pone.0219758. eCollection 2019.

6.

Free-Water Imaging in White and Gray Matter in Parkinson's Disease.

Andica C, Kamagata K, Hatano T, Saito A, Uchida W, Ogawa T, Takeshige-Amano H, Zalesky A, Wada A, Suzuki M, Hagiwara A, Irie R, Hori M, Kumamaru KK, Oyama G, Shimo Y, Umemura A, Pantelis C, Hattori N, Aoki S.

Cells. 2019 Aug 5;8(8). pii: E839. doi: 10.3390/cells8080839.

7.

Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report.

Kamo H, Hatano T, Kanai K, Aoki N, Kamiyama D, Yokoyama K, Takanashi M, Yamashita Y, Shimo Y, Hattori N.

BMC Neurol. 2019 Aug 5;19(1):184. doi: 10.1186/s12883-019-1416-1.

8.

Novel prodrugs of decitabine with greater metabolic stability and less toxicity.

Hattori N, Sako M, Kimura K, Iida N, Takeshima H, Nakata Y, Kono Y, Ushijima T.

Clin Epigenetics. 2019 Aug 1;11(1):111. doi: 10.1186/s13148-019-0709-y.

9.

[Indication for Deep Brain Stimulation].

Shimo Y, Umemura A, Hattori N.

Brain Nerve. 2019 Aug;71(8):885-892. doi: 10.11477/mf.1416201369. Review. Japanese.

PMID:
31346145
10.

Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II-III gliomas to establish genetic predictors of poor prognosis.

Kuwahara K, Ohba S, Nakae S, Hattori N, Pareira ES, Yamada S, Sasaki H, Abe M, Hasegawa M, Hirose Y.

Brain Tumor Pathol. 2019 Jul 19. doi: 10.1007/s10014-019-00348-9. [Epub ahead of print]

PMID:
31324999
11.

Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.

Lee JS, Kanai K, Suzuki M, Kim WS, Yoo HS, Fu Y, Kim DK, Jung BC, Choi M, Oh KW, Li Y, Nakatani M, Nakazato T, Sekimoto S, Funayama M, Yoshino H, Kubo SI, Nishioka K, Sakai R, Ueyama M, Mochizuki H, Lee HJ, Sardi SP, Halliday GM, Nagai Y, Lee PH, Hattori N, Lee SJ.

Brain. 2019 Jul 15. pii: awz205. doi: 10.1093/brain/awz205. [Epub ahead of print]

PMID:
31312839
12.

Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravis.

Nishida Y, Takahashi YK, Kanai T, Nose Y, Ishibashi S, Sanjo N, Uzawa A, Oda F, Ozawa Y, Kuwabara S, Noguchi E, Suzuki S, Nakahara J, Suzuki N, Ogawa T, Yokoyama K, Hattori N, Konno S, Fujioka T, Kawaguchi N, Hatanaka Y, Sonoo M, Kaneko J, Ogino M, Nishiyama K, Nomura K, Yokota T.

Eur J Neurol. 2019 Jul 15. doi: 10.1111/ene.14039. [Epub ahead of print]

PMID:
31309642
13.

Protective Role of Levetiracetam Against Cognitive Impairment And Brain White Matter Damage in Mouse prolonged Cerebral Hypoperfusion.

Inaba T, Miyamoto N, Hira K, Ueno Y, Yamashiro K, Watanabe M, Shimada Y, Hattori N, Urabe T.

Neuroscience. 2019 Aug 21;414:255-264. doi: 10.1016/j.neuroscience.2019.07.015. Epub 2019 Jul 11.

PMID:
31302262
14.

A Case of Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with Polyangiitis.

Yamada T, Masuda T, Yamaguchi K, Sakamoto S, Horimasu Y, Miyamoto S, Nakashima T, Iwamoto H, Hirata S, Fujitaka K, Hamada H, Sugiyama E, Hattori N.

Intern Med. 2019 Jul 10. doi: 10.2169/internalmedicine.3018-19. [Epub ahead of print]

15.

[Development of cardiac tamponade and emergence of arrhythmia during chemotherapy for diffuse large B-cell lymphoma].

Baba Y, Saito B, Shimada S, Sasaki Y, Murai S, Abe M, Fujiwara S, Arai N, Kawaguchi Y, Kabasawa N, Tsukamoto H, Uto Y, Yanagisawa K, Hattori N, Harada H, Nakamaki T.

Rinsho Ketsueki. 2019;60(6):577-581. doi: 10.11406/rinketsu.60.577. Japanese.

PMID:
31281147
16.

Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis.

Yamaguchi K, Iwamoto H, Sakamoto S, Horimasu Y, Masuda T, Miyamoto S, Nakashima T, Ohshimo S, Fujitaka K, Hamada H, Hattori N.

Respirology. 2019 Jul 3. doi: 10.1111/resp.13634. [Epub ahead of print]

PMID:
31270920
17.

Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer.

Nakanishi Y, Masuda T, Yamaguchi K, Sakamoto S, Horimasu Y, Nakashima T, Miyamoto S, Tsutani Y, Iwamoto H, Fujitaka K, Miyata Y, Hamada H, Okada M, Hattori N.

Respir Investig. 2019 Jun 24. pii: S2212-5345(19)30018-8. doi: 10.1016/j.resinv.2019.05.002. [Epub ahead of print]

PMID:
31248832
18.

Changes in acute blood purification therapy in critical care: republication of the article published in the Japanese Journal of Artificial Organs.

Nakada TA, Oda S, Abe R, Hattori N.

J Artif Organs. 2019 Jun 24. doi: 10.1007/s10047-019-01113-7. [Epub ahead of print] Review.

PMID:
31236729
19.

Brain tissue and myelin volumetric analysis in multiple sclerosis at 3T MRI with various in-plane resolutions using synthetic MRI.

Saccenti L, Andica C, Hagiwara A, Yokoyama K, Takemura MY, Fujita S, Maekawa T, Kamagata K, Le Berre A, Hori M, Hattori N, Aoki S.

Neuroradiology. 2019 Jun 18. doi: 10.1007/s00234-019-02241-w. [Epub ahead of print]

PMID:
31209528
20.

Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm study.

Iozumi K, Abe M, Ito Y, Uesugi T, Onoduka T, Kato I, Kato F, Kodama K, Takahashi H, Takeda O, Tomizawa K, Nomiyama T, Fujii M, Mayama J, Muramoto F, Yasuda H, Yamanaka K, Sato T, Oh-I T, Kasai H, Tsuboi R, Hattori N, Maruyama R, Omi T, Shimoyama H, Sei Y, Nakasu I, Nishimoto S, Hata Y, Mochizuki T, Fukuzawa M, Seishima M, Sugiura K, Katayama I, Yamamoto O, Shindo M, Kiryu H, Kusuhara M, Takenaka M, Watanabe S.

J Dermatol. 2019 Aug;46(8):641-651. doi: 10.1111/1346-8138.14935. Epub 2019 Jun 17.

PMID:
31206779
21.

Pneumatosis cystoides intestinalis in pulmonary mycobacterial disease.

Yamasaki M, Teshima H, Okanobu H, Hattori N.

Br J Hosp Med (Lond). 2019 Jun 2;80(6):iii. doi: 10.12968/hmed.2019.80.6.iii. No abstract available.

PMID:
31180773
22.

Deep brain stimulation shows high efficacy in two patients with GCH1 variants.

Daida K, Nishioka K, Shimo Y, Umemura A, Yoshino H, Hattori N.

Parkinsonism Relat Disord. 2019 Jun 3. pii: S1353-8020(19)30263-9. doi: 10.1016/j.parkreldis.2019.06.002. [Epub ahead of print] No abstract available.

PMID:
31178337
23.

Parkinson's disease in the Western Pacific Region.

Lim SY, Tan AH, Ahmad-Annuar A, Klein C, Tan LCS, Rosales RL, Bhidayasiri R, Wu YR, Shang HF, Evans AH, Pal PK, Hattori N, Tan CT, Jeon B, Tan EK, Lang AE.

Lancet Neurol. 2019 Sep;18(9):865-879. doi: 10.1016/S1474-4422(19)30195-4. Epub 2019 Jun 4. Review.

PMID:
31175000
24.

More subjects are required for ventrolateral than dorsolateral prefrontal TMS because of intolerability and potential drop-out.

Han S, Ogawa A, Osada T, Suda A, Tanaka M, Nanjo H, Shimo Y, Hattori N, Konishi S.

PLoS One. 2019 Jun 3;14(6):e0217826. doi: 10.1371/journal.pone.0217826. eCollection 2019.

25.

A metabolic profile of polyamines in parkinson disease: A promising biomarker.

Saiki S, Sasazawa Y, Fujimaki M, Kamagata K, Kaga N, Taka H, Li Y, Souma S, Hatano T, Imamichi Y, Furuya N, Mori A, Oji Y, Ueno SI, Nojiri S, Miura Y, Ueno T, Funayama M, Aoki S, Hattori N.

Ann Neurol. 2019 Aug;86(2):251-263. doi: 10.1002/ana.25516. Epub 2019 Jul 1.

PMID:
31155745
26.

Gray Matter Alterations in Early and Late Relapsing-Remitting Multiple Sclerosis Evaluated with Synthetic Quantitative Magnetic Resonance Imaging.

Andica C, Hagiwara A, Kamagata K, Yokoyama K, Shimoji K, Saito A, Takenaka Y, Nakazawa M, Hori M, Cohen-Adad J, Takemura MY, Hattori N, Aoki S.

Sci Rep. 2019 May 31;9(1):8147. doi: 10.1038/s41598-019-44615-3.

27.

Neuromelanin or DaT-SPECT: which is the better marker for discriminating advanced Parkinson's disease?

Okuzumi A, Hatano T, Kamagata K, Hori M, Mori A, Oji Y, Taniguchi D, Daida K, Shimo Y, Yanagisawa N, Nojiri S, Aoki S, Hattori N.

Eur J Neurol. 2019 May 28. doi: 10.1111/ene.14009. [Epub ahead of print]

PMID:
31136060
28.

Cell-specific overexpression of COMT in dopaminergic neurons of Parkinson's disease.

Kuzumaki N, Suda Y, Iwasawa C, Narita M, Sone T, Watanabe M, Maekawa A, Matsumoto T, Akamatsu W, Igarashi K, Tamura H, Takeshima H, Tawfik VL, Ushijima T, Hattori N, Okano H, Narita M.

Brain. 2019 Jun 1;142(6):1675-1689. doi: 10.1093/brain/awz084.

PMID:
31135049
29.

Endobronchial Diffuse Large B-cell Lymphoma.

Yamasaki M, Matsumoto Y, Hattori N.

Arch Bronconeumol. 2019 May 22. pii: S0300-2896(19)30230-3. doi: 10.1016/j.arbres.2019.04.007. [Epub ahead of print] English, Spanish. No abstract available.

30.

Comparison of anti-aminoacyl-tRNA synthetase antibody-related and idiopathic non-specific interstitial pneumonia.

Shioya S, Masuda T, Yamaguchi K, Sakamoto S, Horimasu Y, Nakashima T, Miyamoto S, Senoo T, Iwamoto H, Ohshimo S, Fujitaka K, Hamada H, Hattori N.

Respir Med. 2019 Jun;152:44-50. doi: 10.1016/j.rmed.2019.04.023. Epub 2019 May 1.

PMID:
31128609
31.

Can cattle visually discriminate between green and dead forages at a short distance while moving in the field?

Hirata M, Arimoto C, Hattori N, Anzai H.

Anim Cogn. 2019 Sep;22(5):707-718. doi: 10.1007/s10071-019-01268-z. Epub 2019 May 24.

PMID:
31127432
32.

Technique and outcome of percutaneous endoscopic transgastric jejunostomy for continuous infusion of levodopa-carbidopa intestinal gel for treatment of Parkinson's disease.

Ishibashi Y, Shimo Y, Yube Y, Oka S, Egawa H, Kohira Y, Kaji S, Kanda S, Oyama G, Hatano T, Hattori N, Fukunaga T.

Scand J Gastroenterol. 2019 May 24:1-6. doi: 10.1080/00365521.2019.1619830. [Epub ahead of print]

PMID:
31125265
33.

Acquired T790M-positive Squamous Cell Lung Carcinoma that Responded to Osimertinib.

Yamasaki M, Funaishi K, Daido W, Hattori N.

Arch Bronconeumol. 2019 May 20. pii: S0300-2896(19)30220-0. doi: 10.1016/j.arbres.2019.04.004. [Epub ahead of print] English, Spanish. No abstract available.

34.

Lambda Sign: Sarcoidosis.

Matsumoto Y, Yamasaki M, Matsumoto N, Taniwaki M, Hattori N.

Arch Bronconeumol. 2019 May 18. pii: S0300-2896(19)30119-X. doi: 10.1016/j.arbres.2019.03.008. [Epub ahead of print] English, Spanish. No abstract available.

35.

Role of B7H3/IL-33 Signaling in Pulmonary Fibrosis-induced Profibrogenic Alterations in Bone Marrow.

Nakashima T, Liu T, Hu B, Wu Z, Ullenbruch M, Omori K, Ding L, Hattori N, Phan SH.

Am J Respir Crit Care Med. 2019 May 18. doi: 10.1164/rccm.201808-1560OC. [Epub ahead of print]

PMID:
31106564
36.

Severe Metastatic Pulmonary Calcification.

Taniwaki M, Kawamoto K, Yamasaki M, Funaishi K, Matsumoto Y, Matsumoto N, Ohashi N, Hattori N.

Am J Med. 2019 May 15. pii: S0002-9343(19)30417-6. doi: 10.1016/j.amjmed.2019.04.031. [Epub ahead of print] No abstract available.

PMID:
31100282
37.

Increased Lysosomal Exocytosis Induced by Lysosomal Ca2+ Channel Agonists Protects Human Dopaminergic Neurons from α-Synuclein Toxicity.

Tsunemi T, Perez-Rosello T, Ishiguro Y, Yoroisaka A, Jeon S, Hamada K, Rammonhan M, Wong YC, Xie Z, Akamatsu W, Mazzulli JR, Surmeier DJ, Hattori N, Krainc D.

J Neurosci. 2019 Jul 17;39(29):5760-5772. doi: 10.1523/JNEUROSCI.3085-18.2019. Epub 2019 May 16.

PMID:
31097622
38.

Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3.

Maeda M, Takeshima H, Iida N, Hattori N, Yamashita S, Moro H, Yasukawa Y, Nishiyama K, Hashimoto T, Sekine S, Ishii G, Ochiai A, Fukagawa T, Katai H, Sakai Y, Ushijima T.

Gut. 2019 May 13. pii: gutjnl-2018-317645. doi: 10.1136/gutjnl-2018-317645. [Epub ahead of print]

PMID:
31085554
39.

Organization of functional modularity in sitting balance response and gait performance after stroke.

Yamasaki HR, An Q, Kinomoto M, Takahashi K, Fujii T, Kogami H, Yang N, Yamakawa H, Tamura Y, Itkonen M, Sonoo M, Alnajjar FSK, Yamashita A, Otomune H, Hattori N, Asama H, Miyai I, Shimoda S.

Clin Biomech (Bristol, Avon). 2019 Jul;67:61-69. doi: 10.1016/j.clinbiomech.2019.04.022. Epub 2019 May 3.

PMID:
31075736
40.

Iron Supply via NCOA4-Mediated Ferritin Degradation Maintains Mitochondrial Functions.

Fujimaki M, Furuya N, Saiki S, Amo T, Imamichi Y, Hattori N.

Mol Cell Biol. 2019 Jun 27;39(14). pii: e00010-19. doi: 10.1128/MCB.00010-19. Print 2019 Jul 15.

PMID:
31061094
41.

Specific mechanisms of subarachnoid hemorrhage accompanied by ischemic stroke in essential thrombocythemia: two case reports and a literature review.

Sugiyama M, Ueno Y, Kamo H, Edahiro Y, Miyamoto N, Yamashiro K, Tanaka R, Shimo Y, Komatsu N, Hattori N.

J Neurol. 2019 Aug;266(8):1869-1878. doi: 10.1007/s00415-019-09347-4. Epub 2019 May 2.

PMID:
31049728
42.

Long-Term Selegiline Monotherapy for the Treatment of Early Parkinson Disease.

Mizuno Y, Hattori N, Kondo T, Nomoto M, Origasa H, Takahashi R, Yamamoto M, Yanagisawa N.

Clin Neuropharmacol. 2019 Jul/Aug;42(4):123-130. doi: 10.1097/WNF.0000000000000343.

PMID:
31045589
43.

Tau aggregation and seeding analyses of two novel MAPT variants found in patients with motor neuron disease and progressive parkinsonism.

Nakayama S, Shimonaka S, Elahi M, Nishioka K, Oji Y, Matsumoto SE, Li Y, Yoshino H, Mogushi K, Hatano T, Sato T, Ikura T, Ito N, Motoi Y, Hattori N.

Neurobiol Aging. 2019 Mar 1. pii: S0197-4580(19)30066-1. doi: 10.1016/j.neurobiolaging.2019.02.016. [Epub ahead of print]

PMID:
31027853
44.
45.

Three-Component Repurposed Technology for Enhanced Expression: Highly Accumulable Transcriptional Activators via Branched Tag Arrays.

Kunii A, Hara Y, Takenaga M, Hattori N, Fukazawa T, Ushijima T, Yamamoto T, Sakuma T.

CRISPR J. 2018 Oct;1:337-347. doi: 10.1089/crispr.2018.0009.

PMID:
31021277
46.

Photochemical generation of the 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) radical from caged nitroxides by near-infrared two-photon irradiation and its cytocidal effect on lung cancer cells.

Yamada A, Abe M, Nishimura Y, Ishizaka S, Namba M, Nakashima T, Shimoji K, Hattori N.

Beilstein J Org Chem. 2019 Apr 10;15:863-873. doi: 10.3762/bjoc.15.84. eCollection 2019.

47.

Corticosteroid therapy for organizing pneumonia in a human T-cell lymphotropic virus type-1 carrier.

Taniwaki M, Yamasaki M, Matsumoto Y, Matsumoto N, Ohashi N, Hattori N.

Pulmonology. 2019 May - Jun;25(3):193-195. doi: 10.1016/j.pulmoe.2019.02.004. Epub 2019 Apr 15. No abstract available.

48.

Involvement of cortical dysfunction in frequent falls in patients with Parkinson's disease.

Otomune H, Mihara M, Hattori N, Fujimoto H, Kajiyama Y, Konaka K, Mitani Y, Watanabe Y, Mochizuki H.

Parkinsonism Relat Disord. 2019 Apr 11. pii: S1353-8020(19)30202-0. doi: 10.1016/j.parkreldis.2019.04.007. [Epub ahead of print]

PMID:
30992233
49.

Bilateral thigh compartment syndromes from extended sitting with forward bending.

Shimada T, Tsunemi T, Hattori A, Nakazato-Taniguchi T, Yasuhara H, Ogaki K, Hattori N.

J Clin Neurosci. 2019 Jun;64:35-37. doi: 10.1016/j.jocn.2019.03.027. Epub 2019 Apr 6.

PMID:
30967313
50.

Multi-year whole-blood transcriptome data for the study of onset and progression of Parkinson's Disease.

Valentine MNZ, Hashimoto K, Fukuhara T, Saiki S, Ishikawa KI, Hattori N, Carninci P.

Sci Data. 2019 Apr 5;6(1):20. doi: 10.1038/s41597-019-0022-9.

Supplemental Content

Loading ...
Support Center